This partnership will give the prime body of medical students access to MEKSI’s innovative AI powered patient consult tool — providing them with access to standardised training anytime, anywhere
MEKSI, a medical education platform that leverages artificial intelligence to help doctors-in-training sharpen their clinical skills, today announced its partnership with the Australian Medical Students’ Association (AMSA Med Ed).
Through this partnership, all members of AMSA Med Ed will be provided with free access to a customised library of cases in the MEKSI learning platform, which currently has a library of 380 Virtual Standardised Patient (VSP) profiles.
MEKSI’s VSPs are designed to replace human actors in the role play component of the Objective Structured Clinical Examination (OSCE), allowing for a consistent training experience that meets worldwide clinical standards, and can be conducted anywhere.
Since the 1970s, role play has been an integral part of the OSCE, and is thus considered a vital tool for classroom learning and assessment. Yet it also has limitations, as role play tends to be time-consuming, allowing the assessment of just one student at a time. In an examination setting, it can be difficult and expensive to organise. For the first time, MEKSI brings the OSCE on to a digital platform, making simultaneous learning possible, and ultimately creating a collaborative classroom experience. In an initial effort to encourage the use of the MEKSI tool for practising OSCEs, MEKSI sponsored AMSA Med Ed Clinical OSCE Night on September 13, 2022.
“AMSA is a peak body of Australian medical students,” said MEKSI CEO Kamalesh Goswami. “Working with them as a content provider is a step towards making our knowledge and innovation available to all medical students in Australia.”
AMSA Med Ed’s collaboration with MEKSI will further support Australian medical students in accessing quality study resources. In conjunction with AMSA Med Ed’s OSCEs stems and rubrics, the MEKSI tool will enable Australian medical students to effectively practice their OSCE skills.
MEKSI’s commitment to patient safety began in 2016 with the granting of its first Australian Innovation Patent. In 2018, MEKSI received funding from Artesian Capital, and became an eligible ESIC (Early Stage Innovation Company), providing tax benefits to potential investors. Subscription packages will launch in the near future. Meanwhile, interested users can try a free case. MEKSI’s main office is located at 165 Ponds Boulevard, The Ponds, NSW 2769 (Phone: +61 2 9629 3732).